Page last updated: 2024-09-03

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone in 1 studies

Compound Research Comparison

Studies
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Trials
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Recent Studies (post-2010)
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Studies
(3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone)
Trials
(3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone)
Recent Studies (post-2010) (3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone)
7502466036

Protein Interaction Comparison

ProteinTaxonomy3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan (IC50)3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone (IC50)
Cystic fibrosis transmembrane conductance regulatorHomo sapiens (human)0.3267
NACHT, LRR and PYD domains-containing protein 3 Homo sapiens (human)6.39

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JY; Hanrahan, JW; Ianowski, JP; Wine, JJ1

Other Studies

1 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone

ArticleYear
Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands.
    Pflugers Archiv : European journal of physiology, 2008, Volume: 457, Issue:2

    Topics: Animals; Benzoates; Capsaicin; Clotrimazole; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Glands; Irritants; Mice; Mice, Inbred CFTR; Mucus; Neurokinin-1 Receptor Antagonists; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Receptors, Neurokinin-1; Respiratory Mucosa; Substance P; Thiazolidines; Time Factors; Trachea; Tryptophan

2008